Bridgefront Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Bridgefront Capital's AMGN Position: Q1 2026 in Review
Bridgefront Capital opened a new position in Amgen (AMGN) in Q1 2026: 8,228 shares worth $2.9M. The stake represents 0.72% of the portfolio and ranks #12 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in AMGN as recently as Q2 2025.
Bridgefront Capital first reported a position in AMGN in Q4 2020 and has held it in 7 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Bridgefront Capital held 8,228 shares of Amgen worth $2.9M as of Q1 2026.
- Amgen was a new Bridgefront Capital position in Q1 2026.
- Amgen made up 0.72% of Bridgefront Capital's portfolio in Q1 2026, its #12 holding.
- Bridgefront Capital first reported a position in Amgen in Q4 2020 and has held it in 7 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.